Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

ST2 and Rg3a As a Biomarker for Predicting of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Hakan Goker, MDPROF., Elifcan Aladag, MD, Yahya Buyukasik, MD, Nelson J. Chao, MD, Umit Akman, Bio., Haluk Demiroglu, MDPROF.

Blood (2019) 134 (Supplement_1): 5684.

https://doi.org/10.1182/blood-2019-121682

Published: 2019

Journal Articles

Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data

Fatih Demirkan, MD, Rafiye Ciftciler, MD, Omur Gokmen Sevindik, MD, Emre Tekgündüz, MD, Mehmet Ali Erkurt, MD, Filiz Vural, MD, Burhan Turgut, MD, Leylagul Kaynar, MD, Kadriye Bahriye Payzin, Mehmet Hilmi Dogu, MD, Volkan Karakus, MD, Fevzi Altuntas, MD, Yahya Buyukasik, MD

Blood (2019) 134 (Supplement_1): 5073.

https://doi.org/10.1182/blood-2019-126006

Published: 2019

Journal Articles

Comparison of the DONOR Lymphocyte Infusion and Second Allogeneic STEM-CELL Transplantation in the Treatment of First Hematological Relapse after Allogeneic STEM-CELL Transplantation in Adults with ACUTE Leukemia

Haluk Demiroglu, MDPROF., Elifcan Aladag, MD, Nelson J. Chao, MD, Yahya Buyukasik, MD, Hakan Goker, MDPROF.

Blood (2019) 134 (Supplement_1): 5698.

https://doi.org/10.1182/blood-2019-121599

Published: 2019

Journal Articles

Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus As an Etiologic and Prognostic Factor (ThREG-NHL01 Study)

Tuncay Aslan, Evren Ozdemir, MD, Aysegul Uner, Elif Gungor, Nevin Alayvaz Aslan, Esra Yildizhan, MD, Abdullah Agit, Serdal Korkmaz, MD, Gulsum Akgun Cagliyan, Ibrahim Barista, MD, Esra Ozhamam, Gulsum Emel Pamuk, MD, Mehmet Turgut, MD PhD, Bulent Eser, Gulsum Ozet, MD, Rahsan Yıldırım, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5332.

https://doi.org/10.1182/blood.V128.22.5332.5332

Published: 2016

Journal Articles

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Adile Begum Bahcecioglu, Sezgin Etgul, Tuncay Aslan, Muruvvet Seda Aydın, Umit Yavuz Malkan, Mufide Okay, Evren Ozdemir, MD, Rafiye Ciftciler, Hakan Goker, MD, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5483.

https://doi.org/10.1182/blood.V128.22.5483.5483

Published: 2016

Journal Articles

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Ebru Koca, MD, Aysun Halacoglu, MD, Umit Yavuz Malkan, MD, Deniz Arica, MD, Sema Karakus, MD, Hakan Goker, MD, Ibrahim C. Haznedaroglu, MD, Nilgun Sayinalp, MD, Yahya Buyukasik, MD

Blood (2014) 124 (21): 5332.

https://doi.org/10.1182/blood.V124.21.5332.5332

Published: 2014

Journal Articles

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

Gursel Gunes, MD, Umit Yavuz Malkan, MD, Salih Aksu, MD, Ibrahim Celalettin Haznedaroglu, MD, Yahya Buyukasik, MD, Nilgun Sayinalp, MD, Osman Ilhami Ozcebe, MD, Hakan Goker, MD, Haluk Demiroglu

Blood (2014) 124 (21): 5091.

https://doi.org/10.1182/blood.V124.21.5091.5091

Published: 2014

Journal Articles

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Umit Yavuz Malkan, MD, Gursel Gunes, MD, Hakan Goker, MD, Eylem Eliacik, MD, Ayse Isik, MD, Nilgun Sayinalp, MD, Ibrahim Celalettin Haznedaroglu, MD, Haluk Demiroglu, Salih Aksu, MD, Osman Ilhami Ozcebe, MD, Muruvvet Seda Balaban, MD, Tuncay Aslan, MD, Sezgin Etgul, MD, Yahya Buyukasik, MD

Blood (2014) 124 (21): 2283.

https://doi.org/10.1182/blood.V124.21.2283.2283

Published: 2014

Journal Articles

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

Hakan Goker, MD, Eylem Eliacik, MD, Fevzi Altuntas, MD, Emre Tekgunduz, MD, Evren Ozdemir, MD, Ayse Isik, MD, Omur Kayikci, MD, Ali Hakan Kaya, MD, Salih Aksu, MD, Ibrahim C. Haznedaroglu, MD, Nilgun Sayinalp, MD, Haluk Demiroglu, Osman Ilhami Ozcebe, MD, Yahya Buyukasik, MD

Blood (2014) 124 (21): 5830.

https://doi.org/10.1182/blood.V124.21.5830.5830

Published: 2014

Journal Articles

Experience With BFM 95 Pediatric Regimen In Adult ACUTE Lymphoblastic Leukemia

Hakan Goker, MD, Eylem Eliacik, MD, Ayse Isik, MD., Ibrahim C. Haznedaroglu, MD, Prof, Nilgun Sayinalp, MD, Salih Aksu, MD, Osman Ozcebe, MD, Yahya Buyukasik, MD.

Blood (2013) 122 (21): 5015.

https://doi.org/10.1182/blood.V122.21.5015.5015

Published: 2013

Journal Articles

Pyrimidine 5′ Nucleotidase-1 (P5N-1) Deficiency Associated with 4 Novel Mutations in 5 New Turkish Families: Genotype-Phenotype Analysis.

Gunay Balta, PhD, Aytemiz Gurgey, MD, Fatma Gumruk, MD, Yahya Buyukasik, MD, Meral Beksac, MD, Cigdem Altay, MD

Blood (2006) 108 (11): 3743.

https://doi.org/10.1182/blood.V108.11.3743.3743

Published: 2006

Journal Articles

Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia.

Yavuz Beyazit, MD, Salih Aksu, MD, Ibrahim Celalettin Haznedaroglu, MD, Murat Kekilli, MD, Muge Misirlioglu, MD, Serdar Tuncer, MD, Ebru Koca, MD, Deniz Cetiner, MD, Yahya Buyukasik, MD, Nilgun Sayinalp, MD, Hakan Goker, MD, Osman Ilhami Ozcebe, MD

Blood (2005) 106 (11): 4567.

https://doi.org/10.1182/blood.V106.11.4567.4567

Published: 2005

NARROW

ST2 and Rg3a As a Biomarker for Predicting of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data

Comparison of the DONOR Lymphocyte Infusion and Second Allogeneic STEM-CELL Transplantation in the Treatment of First Hematological Relapse after Allogeneic STEM-CELL Transplantation in Adults with ACUTE Leukemia

Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus As an Etiologic and Prognostic Factor (ThREG-NHL01 Study)

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

Experience With BFM 95 Pediatric Regimen In Adult ACUTE Lymphoblastic Leukemia

Pyrimidine 5′ Nucleotidase-1 (P5N-1) Deficiency Associated with 4 Novel Mutations in 5 New Turkish Families: Genotype-Phenotype Analysis.

Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only